Dwight Klemm
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipocytes | 17 | 2022 | 204 | 3.240 |
Why?
| Cyclic AMP Response Element-Binding Protein | 19 | 2014 | 141 | 3.020 |
Why?
| Adipose Tissue | 10 | 2022 | 589 | 1.760 |
Why?
| Muscle, Smooth, Vascular | 10 | 2016 | 417 | 1.530 |
Why?
| Pulmonary Artery | 11 | 2013 | 1030 | 1.380 |
Why?
| Bone Marrow Cells | 5 | 2021 | 294 | 1.270 |
Why?
| Myocytes, Smooth Muscle | 5 | 2016 | 245 | 1.030 |
Why?
| Cell Differentiation | 16 | 2021 | 1900 | 0.880 |
Why?
| Adipocytes, White | 2 | 2015 | 17 | 0.850 |
Why?
| Thiazolidinediones | 4 | 2010 | 137 | 0.840 |
Why?
| Leptin | 3 | 2022 | 218 | 0.810 |
Why?
| Stem Cells | 5 | 2017 | 578 | 0.760 |
Why?
| Cell Lineage | 6 | 2019 | 334 | 0.750 |
Why?
| Hypoxia | 7 | 2013 | 1036 | 0.720 |
Why?
| PPAR gamma | 6 | 2009 | 182 | 0.690 |
Why?
| Insulin | 8 | 2022 | 2315 | 0.600 |
Why?
| Platelet-Derived Growth Factor | 2 | 2010 | 88 | 0.590 |
Why?
| Animals | 53 | 2024 | 34479 | 0.560 |
Why?
| Integrin beta1 | 1 | 2017 | 19 | 0.560 |
Why?
| Hypertension, Pulmonary | 8 | 2014 | 1745 | 0.540 |
Why?
| Promoter Regions, Genetic | 12 | 2015 | 1198 | 0.530 |
Why?
| Mice | 29 | 2022 | 16602 | 0.490 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 14 | 0.450 |
Why?
| Wnt Proteins | 2 | 2020 | 126 | 0.450 |
Why?
| Myeloid Cells | 2 | 2017 | 142 | 0.440 |
Why?
| Adipogenesis | 2 | 2017 | 49 | 0.440 |
Why?
| Rats | 18 | 2024 | 5165 | 0.430 |
Why?
| Rats, Inbred WKY | 5 | 2013 | 33 | 0.420 |
Why?
| Hematopoietic Stem Cells | 4 | 2022 | 378 | 0.420 |
Why?
| Flow Cytometry | 3 | 2014 | 1142 | 0.420 |
Why?
| rho-Associated Kinases | 1 | 2013 | 83 | 0.420 |
Why?
| Cell Separation | 2 | 2014 | 313 | 0.410 |
Why?
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2007 | 31 | 0.390 |
Why?
| CREB-Binding Protein | 3 | 2008 | 27 | 0.370 |
Why?
| Cells, Cultured | 14 | 2017 | 4001 | 0.370 |
Why?
| Intra-Abdominal Fat | 1 | 2011 | 88 | 0.350 |
Why?
| Transcription, Genetic | 10 | 2001 | 1404 | 0.350 |
Why?
| Casein Kinase II | 1 | 2010 | 21 | 0.340 |
Why?
| Protein Kinases | 5 | 2004 | 309 | 0.330 |
Why?
| Hydrogen Peroxide | 1 | 2011 | 308 | 0.330 |
Why?
| Mesoderm | 1 | 2010 | 136 | 0.320 |
Why?
| Cell Division | 5 | 2009 | 778 | 0.320 |
Why?
| Cell Nucleus | 8 | 2010 | 578 | 0.310 |
Why?
| Protein Kinase Inhibitors | 3 | 2013 | 872 | 0.310 |
Why?
| Adenovirus E1A Proteins | 2 | 2000 | 11 | 0.310 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2001 | 281 | 0.310 |
Why?
| Cyclin D1 | 1 | 2008 | 63 | 0.310 |
Why?
| Phosphoenolpyruvate Carboxykinase (GTP) | 6 | 1997 | 31 | 0.300 |
Why?
| Trans-Activators | 3 | 2001 | 381 | 0.300 |
Why?
| Activating Transcription Factor 1 | 3 | 2006 | 9 | 0.290 |
Why?
| Nuclear Proteins | 5 | 2001 | 657 | 0.290 |
Why?
| Energy Metabolism | 4 | 2024 | 831 | 0.280 |
Why?
| Wnt Signaling Pathway | 3 | 2020 | 165 | 0.280 |
Why?
| Cell Proliferation | 6 | 2013 | 2344 | 0.270 |
Why?
| Gene Expression Regulation | 7 | 2010 | 2505 | 0.270 |
Why?
| Blotting, Western | 6 | 2011 | 1164 | 0.260 |
Why?
| Cyclic AMP | 4 | 2000 | 229 | 0.250 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2006 | 145 | 0.250 |
Why?
| Reverse Transcriptase Inhibitors | 1 | 2006 | 81 | 0.250 |
Why?
| Signal Transduction | 5 | 2013 | 4826 | 0.240 |
Why?
| Cell Movement | 3 | 2011 | 936 | 0.240 |
Why?
| Rats, Wistar | 2 | 2024 | 397 | 0.230 |
Why?
| Adiponectin | 2 | 2022 | 234 | 0.230 |
Why?
| Phosphorylation | 10 | 2010 | 1681 | 0.230 |
Why?
| Neoplasm Proteins | 2 | 2014 | 421 | 0.230 |
Why?
| Mitochondria, Muscle | 2 | 2016 | 110 | 0.220 |
Why?
| Cell Line | 12 | 2020 | 2731 | 0.220 |
Why?
| 3T3-L1 Cells | 4 | 2008 | 34 | 0.220 |
Why?
| Proto-Oncogene Proteins c-akt | 5 | 2013 | 421 | 0.220 |
Why?
| Adaptation, Physiological | 3 | 2016 | 514 | 0.220 |
Why?
| Ovariectomy | 1 | 2024 | 136 | 0.210 |
Why?
| Arteriosclerosis | 1 | 2003 | 88 | 0.210 |
Why?
| Adipose Tissue, White | 2 | 2024 | 37 | 0.210 |
Why?
| Blood Vessels | 2 | 2007 | 181 | 0.210 |
Why?
| Follicle Stimulating Hormone | 1 | 2024 | 235 | 0.200 |
Why?
| Pulmonary Fibrosis | 4 | 2017 | 377 | 0.200 |
Why?
| Lipid Metabolism | 1 | 2006 | 491 | 0.200 |
Why?
| Transcription Factors | 8 | 2003 | 1628 | 0.200 |
Why?
| Diphtheria Toxin | 1 | 2022 | 64 | 0.190 |
Why?
| Lung | 6 | 2020 | 3743 | 0.190 |
Why?
| Ecdysterone | 1 | 2001 | 3 | 0.190 |
Why?
| Proto-Oncogene Proteins | 2 | 2004 | 634 | 0.190 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2012 | 357 | 0.190 |
Why?
| Neovascularization, Pathologic | 2 | 2020 | 290 | 0.180 |
Why?
| Estradiol | 1 | 2024 | 486 | 0.180 |
Why?
| Metabolic Diseases | 1 | 2021 | 105 | 0.170 |
Why?
| Mice, Transgenic | 4 | 2017 | 2071 | 0.170 |
Why?
| Receptors, Glucocorticoid | 2 | 2001 | 148 | 0.170 |
Why?
| Hypertrophy, Right Ventricular | 2 | 2013 | 133 | 0.170 |
Why?
| Airway Remodeling | 1 | 2020 | 58 | 0.170 |
Why?
| Phosphatidylglycerols | 3 | 1988 | 24 | 0.170 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2001 | 258 | 0.170 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2021 | 203 | 0.170 |
Why?
| Animal Nutritional Physiological Phenomena | 1 | 1999 | 14 | 0.160 |
Why?
| Muscle Proteins | 1 | 2001 | 221 | 0.160 |
Why?
| Pulmonary Circulation | 2 | 2013 | 416 | 0.160 |
Why?
| Endothelium, Vascular | 2 | 2020 | 847 | 0.160 |
Why?
| Nitric Oxide Synthase Type III | 3 | 2015 | 197 | 0.160 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2016 | 173 | 0.160 |
Why?
| Polycystic Kidney Diseases | 1 | 2019 | 63 | 0.150 |
Why?
| RNA, Small Interfering | 3 | 2011 | 571 | 0.150 |
Why?
| Proto-Oncogene Proteins c-sis | 2 | 2010 | 34 | 0.150 |
Why?
| Metabolome | 1 | 2021 | 319 | 0.150 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 1996 | 1351 | 0.150 |
Why?
| Pericytes | 2 | 2017 | 25 | 0.150 |
Why?
| Adipose Tissue, Brown | 1 | 2018 | 51 | 0.150 |
Why?
| Leukemia, Experimental | 2 | 1988 | 27 | 0.150 |
Why?
| Transfection | 8 | 2001 | 893 | 0.150 |
Why?
| Tumor Cells, Cultured | 6 | 1998 | 930 | 0.140 |
Why?
| Protein Stability | 2 | 2017 | 160 | 0.140 |
Why?
| Macrophages | 2 | 2017 | 1460 | 0.140 |
Why?
| Apoptosis | 2 | 2006 | 2435 | 0.130 |
Why?
| Fibrosis | 1 | 2019 | 512 | 0.130 |
Why?
| Phosphoprotein Phosphatases | 2 | 1994 | 67 | 0.130 |
Why?
| Extracellular Matrix | 2 | 2013 | 495 | 0.130 |
Why?
| Fibrin | 1 | 2017 | 68 | 0.130 |
Why?
| Recombinant Fusion Proteins | 4 | 2006 | 634 | 0.130 |
Why?
| Microvessels | 1 | 2017 | 79 | 0.130 |
Why?
| Humans | 31 | 2021 | 128417 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2000 | 567 | 0.130 |
Why?
| Cell Fusion | 1 | 2015 | 51 | 0.130 |
Why?
| Estrogens | 1 | 2018 | 342 | 0.130 |
Why?
| Cytotoxicity, Immunologic | 1 | 1996 | 218 | 0.120 |
Why?
| Adamantane | 1 | 2015 | 15 | 0.120 |
Why?
| Exercise | 2 | 2018 | 1929 | 0.120 |
Why?
| Dipeptides | 1 | 2015 | 48 | 0.120 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 1994 | 18 | 0.120 |
Why?
| Mice, Inbred C57BL | 9 | 2016 | 5272 | 0.120 |
Why?
| Mice, Knockout | 6 | 2016 | 2755 | 0.120 |
Why?
| Male | 13 | 2020 | 62857 | 0.120 |
Why?
| Interferons | 1 | 1996 | 192 | 0.110 |
Why?
| Free Radical Scavengers | 2 | 2011 | 78 | 0.110 |
Why?
| Vasodilator Agents | 2 | 2013 | 321 | 0.110 |
Why?
| Gene Expression Regulation, Viral | 1 | 1994 | 84 | 0.110 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 26 | 0.110 |
Why?
| Arterioles | 1 | 2013 | 41 | 0.110 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2014 | 130 | 0.110 |
Why?
| Models, Biological | 3 | 2021 | 1691 | 0.110 |
Why?
| Female | 12 | 2024 | 68153 | 0.110 |
Why?
| Bucladesine | 4 | 2000 | 24 | 0.110 |
Why?
| Pluripotent Stem Cells | 1 | 2014 | 78 | 0.110 |
Why?
| Glucocorticoids | 1 | 1997 | 571 | 0.100 |
Why?
| Cell Survival | 2 | 2006 | 1077 | 0.100 |
Why?
| PPAR alpha | 2 | 2010 | 59 | 0.100 |
Why?
| Bleomycin | 2 | 2011 | 240 | 0.100 |
Why?
| Killer Cells, Natural | 1 | 1996 | 426 | 0.100 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| Diabetes Mellitus | 2 | 2014 | 999 | 0.100 |
Why?
| Serine | 2 | 2006 | 135 | 0.100 |
Why?
| Enzyme Activation | 5 | 2010 | 799 | 0.100 |
Why?
| Neoplastic Stem Cells | 1 | 2016 | 386 | 0.100 |
Why?
| Binding Sites | 2 | 2008 | 1236 | 0.090 |
Why?
| Base Sequence | 7 | 2003 | 2135 | 0.090 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 572 | 0.090 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 1999 | 0.090 |
Why?
| Mutation | 4 | 2008 | 3689 | 0.090 |
Why?
| Calcification, Physiologic | 1 | 2011 | 34 | 0.090 |
Why?
| Cytosol | 2 | 2010 | 214 | 0.090 |
Why?
| Diet, High-Fat | 1 | 2012 | 238 | 0.090 |
Why?
| Adipocytes, Brown | 1 | 2010 | 7 | 0.090 |
Why?
| Cytogenetic Analysis | 1 | 2010 | 33 | 0.090 |
Why?
| Cell Hypoxia | 1 | 2011 | 229 | 0.090 |
Why?
| Liver | 6 | 2024 | 1826 | 0.090 |
Why?
| Enzyme Inhibitors | 1 | 2013 | 809 | 0.090 |
Why?
| Hyperoxia | 2 | 2009 | 87 | 0.080 |
Why?
| Osteoblasts | 1 | 2011 | 123 | 0.080 |
Why?
| Motor Activity | 1 | 2015 | 668 | 0.080 |
Why?
| Leukocyte Common Antigens | 2 | 2007 | 81 | 0.080 |
Why?
| Molecular Sequence Data | 7 | 2000 | 2819 | 0.080 |
Why?
| Active Transport, Cell Nucleus | 2 | 2009 | 113 | 0.080 |
Why?
| Extracellular Space | 1 | 2010 | 120 | 0.080 |
Why?
| Reactive Oxygen Species | 2 | 2010 | 577 | 0.080 |
Why?
| Genes | 1 | 1990 | 226 | 0.080 |
Why?
| In Vitro Techniques | 3 | 2007 | 1039 | 0.080 |
Why?
| Carrier Proteins | 2 | 2006 | 732 | 0.080 |
Why?
| Lipoproteins, LDL | 1 | 2010 | 126 | 0.080 |
Why?
| Kinetics | 4 | 2000 | 1615 | 0.080 |
Why?
| Osteogenesis | 1 | 2011 | 175 | 0.080 |
Why?
| DNA-Binding Proteins | 5 | 2003 | 1421 | 0.080 |
Why?
| Cell Culture Techniques | 1 | 2011 | 345 | 0.080 |
Why?
| Mice, Nude | 2 | 2011 | 682 | 0.080 |
Why?
| 3T3 Cells | 2 | 2000 | 151 | 0.080 |
Why?
| Neprilysin | 1 | 2009 | 47 | 0.080 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2001 | 215 | 0.080 |
Why?
| Dietary Fats | 2 | 2010 | 301 | 0.080 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 399 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 756 | 0.070 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2011 | 224 | 0.070 |
Why?
| Superoxide Dismutase | 1 | 2010 | 326 | 0.070 |
Why?
| Respiratory System | 1 | 2009 | 152 | 0.070 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 172 | 0.070 |
Why?
| Insulin Resistance | 3 | 2012 | 1164 | 0.070 |
Why?
| Mitochondria | 1 | 2014 | 848 | 0.070 |
Why?
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 323 | 0.070 |
Why?
| Protein Binding | 2 | 2008 | 2103 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 257 | 0.070 |
Why?
| Disease Models, Animal | 5 | 2015 | 3937 | 0.070 |
Why?
| Phosphatidylinositols | 1 | 1987 | 57 | 0.070 |
Why?
| Perilipin-1 | 1 | 2006 | 16 | 0.070 |
Why?
| Microscopy, Phase-Contrast | 1 | 2006 | 15 | 0.070 |
Why?
| Up-Regulation | 1 | 2010 | 825 | 0.070 |
Why?
| Collagenases | 1 | 2006 | 23 | 0.070 |
Why?
| Endothelial Cells | 2 | 2014 | 698 | 0.070 |
Why?
| CD11 Antigens | 1 | 2006 | 29 | 0.070 |
Why?
| Elastin | 1 | 2006 | 77 | 0.070 |
Why?
| Obesity | 2 | 2012 | 2858 | 0.070 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 68 | 0.070 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2006 | 48 | 0.070 |
Why?
| Spleen | 1 | 1988 | 507 | 0.070 |
Why?
| Proteasome Inhibitors | 1 | 2006 | 44 | 0.070 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 500 | 0.070 |
Why?
| Ubiquitin | 1 | 2006 | 62 | 0.060 |
Why?
| Adenosine Triphosphate | 2 | 2004 | 471 | 0.060 |
Why?
| Age Factors | 2 | 2010 | 3103 | 0.060 |
Why?
| Myofibroblasts | 2 | 2019 | 119 | 0.060 |
Why?
| Interleukin-4 | 2 | 1997 | 212 | 0.060 |
Why?
| Fatty Acids, Unsaturated | 1 | 2006 | 95 | 0.060 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 2000 | 150 | 0.060 |
Why?
| Atherosclerosis | 1 | 2010 | 403 | 0.060 |
Why?
| HIV Protease Inhibitors | 1 | 2006 | 62 | 0.060 |
Why?
| Acetylcysteine | 1 | 2006 | 140 | 0.060 |
Why?
| Stem Cell Transplantation | 1 | 2006 | 165 | 0.060 |
Why?
| Bone Marrow Transplantation | 1 | 2006 | 268 | 0.060 |
Why?
| Cattle | 3 | 2004 | 960 | 0.060 |
Why?
| Green Fluorescent Proteins | 1 | 2006 | 380 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2016 | 2051 | 0.060 |
Why?
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 34 | 0.060 |
Why?
| Rats, Sprague-Dawley | 4 | 2010 | 2239 | 0.060 |
Why?
| Fatty Liver | 1 | 2007 | 231 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 940 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1945 | 0.060 |
Why?
| Collagen | 1 | 2006 | 429 | 0.060 |
Why?
| Phosphoproteins | 1 | 2006 | 327 | 0.060 |
Why?
| Aorta | 2 | 2010 | 404 | 0.060 |
Why?
| T-Lymphocytes | 2 | 2011 | 1923 | 0.050 |
Why?
| Protein Phosphatase 2 | 2 | 1994 | 38 | 0.050 |
Why?
| Genes, Dominant | 1 | 2003 | 90 | 0.050 |
Why?
| DNA Methylation | 1 | 2008 | 604 | 0.050 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1688 | 0.050 |
Why?
| Graft Occlusion, Vascular | 1 | 2003 | 39 | 0.050 |
Why?
| Drug Therapy, Combination | 1 | 2006 | 1009 | 0.050 |
Why?
| Lung Diseases | 1 | 2009 | 715 | 0.050 |
Why?
| Biomarkers | 1 | 2014 | 3880 | 0.050 |
Why?
| Ovary | 1 | 2024 | 210 | 0.050 |
Why?
| Familial Primary Pulmonary Hypertension | 2 | 2014 | 183 | 0.050 |
Why?
| Adiposity | 1 | 2007 | 504 | 0.050 |
Why?
| Sequence Alignment | 2 | 2000 | 329 | 0.050 |
Why?
| Genes, Reporter | 2 | 2000 | 265 | 0.050 |
Why?
| Genetic Therapy | 1 | 2003 | 290 | 0.050 |
Why?
| Protein Prenylation | 1 | 2001 | 34 | 0.050 |
Why?
| Fatty Acid Synthases | 1 | 2001 | 24 | 0.050 |
Why?
| Monosaccharide Transport Proteins | 1 | 2001 | 49 | 0.050 |
Why?
| Fibroblasts | 2 | 2009 | 935 | 0.050 |
Why?
| Glucose Transporter Type 4 | 1 | 2001 | 39 | 0.050 |
Why?
| Hypoglycemic Agents | 2 | 2007 | 1212 | 0.050 |
Why?
| Hypertension | 1 | 2010 | 1235 | 0.040 |
Why?
| Polymerase Chain Reaction | 3 | 2011 | 1020 | 0.040 |
Why?
| Fluorescent Antibody Technique | 1 | 2001 | 371 | 0.040 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2015 | 2429 | 0.040 |
Why?
| Myelin P2 Protein | 1 | 2000 | 2 | 0.040 |
Why?
| Fatty Acid-Binding Protein 7 | 1 | 2000 | 4 | 0.040 |
Why?
| Consensus Sequence | 1 | 2000 | 72 | 0.040 |
Why?
| Body Composition | 1 | 2024 | 644 | 0.040 |
Why?
| Oxidation-Reduction | 2 | 2016 | 1001 | 0.040 |
Why?
| Antigens, Differentiation | 1 | 2000 | 82 | 0.040 |
Why?
| Fatty Acid-Binding Proteins | 1 | 2000 | 67 | 0.040 |
Why?
| Body Weight | 1 | 2024 | 928 | 0.040 |
Why?
| Ligands | 1 | 2021 | 614 | 0.040 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2019 | 26 | 0.040 |
Why?
| Blood Pressure | 1 | 2006 | 1728 | 0.040 |
Why?
| Open Reading Frames | 1 | 2000 | 116 | 0.040 |
Why?
| Vascular System Injuries | 1 | 2020 | 72 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 2001 | 302 | 0.040 |
Why?
| Leukocytes, Mononuclear | 2 | 2001 | 539 | 0.040 |
Why?
| Dexamethasone | 1 | 2001 | 338 | 0.040 |
Why?
| Kidney Tubules, Proximal | 1 | 2019 | 125 | 0.040 |
Why?
| Tamoxifen | 1 | 2019 | 200 | 0.040 |
Why?
| beta Catenin | 1 | 2020 | 219 | 0.040 |
Why?
| Transcriptome | 1 | 2024 | 881 | 0.040 |
Why?
| Recombinant Proteins | 3 | 2003 | 1281 | 0.040 |
Why?
| Pulmonary Emphysema | 1 | 2020 | 244 | 0.040 |
Why?
| Molecular Weight | 2 | 1988 | 331 | 0.040 |
Why?
| Adrenal Cortex Hormones | 1 | 2001 | 518 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2001 | 1664 | 0.030 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 40 | 0.030 |
Why?
| Drug Resistance | 1 | 1997 | 163 | 0.030 |
Why?
| Gluconeogenesis | 1 | 1997 | 73 | 0.030 |
Why?
| Heart Failure | 1 | 2010 | 2145 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2001 | 1185 | 0.030 |
Why?
| Gonads | 1 | 2016 | 23 | 0.030 |
Why?
| Blast Crisis | 1 | 2016 | 32 | 0.030 |
Why?
| CD36 Antigens | 1 | 2016 | 35 | 0.030 |
Why?
| Cytoprotection | 1 | 2016 | 50 | 0.030 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1996 | 15 | 0.030 |
Why?
| Liver Neoplasms, Experimental | 1 | 1996 | 28 | 0.030 |
Why?
| Lipolysis | 1 | 2016 | 40 | 0.030 |
Why?
| Retinoblastoma Protein | 1 | 1996 | 54 | 0.030 |
Why?
| Interleukin-2 | 1 | 1997 | 434 | 0.030 |
Why?
| Animals, Newborn | 2 | 2009 | 803 | 0.030 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1995 | 28 | 0.030 |
Why?
| Vasoconstriction | 1 | 2017 | 185 | 0.030 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 1995 | 29 | 0.030 |
Why?
| Menopause | 1 | 2018 | 291 | 0.030 |
Why?
| Hypersensitivity, Immediate | 1 | 1995 | 43 | 0.030 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2016 | 111 | 0.030 |
Why?
| Neutrophils | 1 | 2001 | 1193 | 0.030 |
Why?
| Tumor Burden | 1 | 2016 | 283 | 0.030 |
Why?
| Superoxides | 1 | 2016 | 196 | 0.030 |
Why?
| Organelle Biogenesis | 1 | 2015 | 14 | 0.030 |
Why?
| Point Mutation | 1 | 1996 | 223 | 0.030 |
Why?
| Structure-Activity Relationship | 1 | 1996 | 530 | 0.030 |
Why?
| Exons | 1 | 1996 | 338 | 0.030 |
Why?
| Protein Phosphatase 1 | 1 | 1994 | 33 | 0.030 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 1994 | 53 | 0.030 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 45 | 0.030 |
Why?
| Gene Deletion | 1 | 1996 | 370 | 0.030 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2015 | 112 | 0.030 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 154 | 0.030 |
Why?
| Oligonucleotide Probes | 2 | 1990 | 50 | 0.030 |
Why?
| Okadaic Acid | 1 | 1993 | 14 | 0.030 |
Why?
| Ethers, Cyclic | 1 | 1993 | 7 | 0.030 |
Why?
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 11 | 0.030 |
Why?
| Fatty Acids | 1 | 2016 | 415 | 0.030 |
Why?
| Asthma | 2 | 1997 | 2213 | 0.030 |
Why?
| Oligodeoxyribonucleotides | 1 | 1993 | 138 | 0.030 |
Why?
| Macromolecular Substances | 1 | 1993 | 211 | 0.030 |
Why?
| Amino Acid Sequence | 2 | 1995 | 2040 | 0.030 |
Why?
| Mitochondrial Proteins | 1 | 2015 | 244 | 0.020 |
Why?
| Physical Conditioning, Animal | 1 | 2015 | 230 | 0.020 |
Why?
| Antioxidants | 2 | 2009 | 538 | 0.020 |
Why?
| Cloning, Molecular | 1 | 1993 | 522 | 0.020 |
Why?
| Respiratory Mucosa | 1 | 2014 | 304 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 377 | 0.020 |
Why?
| Drug Resistance, Neoplasm | 1 | 2016 | 749 | 0.020 |
Why?
| Glutamate-Ammonia Ligase | 1 | 1991 | 7 | 0.020 |
Why?
| Integrin-Binding Sialoprotein | 1 | 2011 | 5 | 0.020 |
Why?
| Osteocalcin | 1 | 2011 | 36 | 0.020 |
Why?
| Mice, Inbred ICR | 1 | 2011 | 107 | 0.020 |
Why?
| Carcinoma, Hepatocellular | 1 | 1993 | 270 | 0.020 |
Why?
| Nitrosation | 1 | 2010 | 8 | 0.020 |
Why?
| Early Growth Response Protein 1 | 1 | 2010 | 26 | 0.020 |
Why?
| Nitric Oxide | 1 | 2016 | 882 | 0.020 |
Why?
| Rats, Inbred SHR | 1 | 2010 | 43 | 0.020 |
Why?
| Templates, Genetic | 1 | 1990 | 61 | 0.020 |
Why?
| Receptors, LDL | 1 | 2010 | 45 | 0.020 |
Why?
| Immunity, Innate | 1 | 1996 | 802 | 0.020 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1990 | 87 | 0.020 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2016 | 591 | 0.020 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 160 | 0.020 |
Why?
| Tyrosine | 1 | 2010 | 217 | 0.020 |
Why?
| Bronchoconstriction | 1 | 2009 | 32 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 163 | 0.020 |
Why?
| Interleukin-3 | 1 | 1988 | 24 | 0.020 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 269 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1988 | 150 | 0.020 |
Why?
| Capillary Permeability | 1 | 2009 | 131 | 0.020 |
Why?
| Tissue Scaffolds | 1 | 2011 | 199 | 0.020 |
Why?
| Muscle, Smooth | 1 | 2009 | 145 | 0.020 |
Why?
| Lung Injury | 1 | 2011 | 199 | 0.020 |
Why?
| Time Factors | 2 | 2010 | 6482 | 0.020 |
Why?
| Liver Neoplasms | 1 | 1993 | 633 | 0.020 |
Why?
| Treatment Outcome | 2 | 2015 | 10151 | 0.020 |
Why?
| DNA Primers | 1 | 2009 | 510 | 0.020 |
Why?
| Infant, Newborn, Diseases | 1 | 2009 | 108 | 0.020 |
Why?
| Species Specificity | 2 | 2001 | 568 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 445 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 2 | 2003 | 358 | 0.020 |
Why?
| Down-Regulation | 1 | 2010 | 631 | 0.020 |
Why?
| Subcellular Fractions | 1 | 1987 | 80 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 81 | 0.020 |
Why?
| Palmitates | 1 | 2007 | 18 | 0.020 |
Why?
| Protein Kinase C | 1 | 1988 | 253 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2009 | 356 | 0.020 |
Why?
| Microcirculation | 1 | 2007 | 137 | 0.020 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 57 | 0.020 |
Why?
| Manganese | 1 | 1987 | 60 | 0.020 |
Why?
| Infant, Newborn | 2 | 2009 | 5687 | 0.020 |
Why?
| Stress, Physiological | 1 | 2010 | 410 | 0.020 |
Why?
| Stearoyl-CoA Desaturase | 1 | 2007 | 62 | 0.020 |
Why?
| Magnesium | 1 | 1987 | 150 | 0.020 |
Why?
| Tissue Distribution | 1 | 1987 | 291 | 0.020 |
Why?
| Placenta | 1 | 1993 | 716 | 0.020 |
Why?
| Substrate Specificity | 1 | 1987 | 365 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2011 | 817 | 0.020 |
Why?
| Inflammation | 1 | 2016 | 2654 | 0.020 |
Why?
| Triglycerides | 1 | 2007 | 523 | 0.010 |
Why?
| Cytokines | 1 | 2012 | 1983 | 0.010 |
Why?
| Young Adult | 1 | 2020 | 12312 | 0.010 |
Why?
| Hemodynamics | 1 | 2009 | 1081 | 0.010 |
Why?
| Genotype | 1 | 2009 | 1828 | 0.010 |
Why?
| DNA | 3 | 1997 | 1390 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 267 | 0.010 |
Why?
| Metformin | 1 | 2007 | 312 | 0.010 |
Why?
| Histones | 1 | 1988 | 586 | 0.010 |
Why?
| Chronic Disease | 1 | 2009 | 1705 | 0.010 |
Why?
| Phenotype | 1 | 2011 | 3044 | 0.010 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2007 | 375 | 0.010 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2004 | 380 | 0.010 |
Why?
| RNA, Messenger | 2 | 2001 | 2675 | 0.010 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2001 | 48 | 0.010 |
Why?
| Aged | 1 | 2020 | 21953 | 0.010 |
Why?
| Pregnancy | 1 | 1993 | 6357 | 0.010 |
Why?
| Risk Assessment | 1 | 2010 | 3232 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 2264 | 0.010 |
Why?
| Interleukin-8 | 1 | 2001 | 258 | 0.010 |
Why?
| Aging | 1 | 2010 | 1750 | 0.010 |
Why?
| Cell Death | 1 | 2001 | 348 | 0.010 |
Why?
| Middle Aged | 1 | 2020 | 30889 | 0.010 |
Why?
| Adult | 2 | 2020 | 35299 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 2001 | 1228 | 0.010 |
Why?
| Chickens | 1 | 1997 | 187 | 0.010 |
Why?
| Glucose | 1 | 2001 | 982 | 0.010 |
Why?
| Plasmids | 1 | 1997 | 354 | 0.010 |
Why?
| Gene Expression | 1 | 2001 | 1456 | 0.010 |
Why?
| Lymphokines | 1 | 1995 | 115 | 0.010 |
Why?
| Luciferases | 1 | 1995 | 147 | 0.010 |
Why?
| Nucleic Acid Hybridization | 1 | 1995 | 188 | 0.010 |
Why?
| Burkitt Lymphoma | 1 | 1995 | 56 | 0.010 |
Why?
| Oxidative Stress | 1 | 2001 | 1176 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 147 | 0.010 |
Why?
| Peptide Mapping | 1 | 1994 | 61 | 0.010 |
Why?
| Fungal Proteins | 1 | 1995 | 127 | 0.010 |
Why?
| Interleukins | 1 | 1995 | 242 | 0.010 |
Why?
| Bezoars | 1 | 1973 | 4 | 0.010 |
Why?
| Stomach | 1 | 1973 | 109 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 37 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1991 | 26 | 0.010 |
Why?
| Autoradiography | 1 | 1991 | 73 | 0.010 |
Why?
| Restriction Mapping | 1 | 1990 | 74 | 0.010 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 1990 | 37 | 0.010 |
Why?
| DNA Transposable Elements | 1 | 1991 | 118 | 0.010 |
Why?
| Introns | 1 | 1991 | 249 | 0.010 |
Why?
| HeLa Cells | 1 | 1991 | 603 | 0.010 |
Why?
| Escherichia coli | 1 | 1990 | 765 | 0.000 |
Why?
| Radiography | 1 | 1973 | 859 | 0.000 |
Why?
|
|
Klemm's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|